Answers are grounded in this paper and cite their sources.
Objectives Inflammation is thought to drive chronic venous disease. The aggregate index of systemic inflammation combines neutrophil, monocyte, platelet, and lymphocyte counts, but it has not been studied in relation to the clinical severity of chronic venous disease. We examined whether it reflects the clinical severity of chronic venous disease. Patients and methods This single-center retrospective study included 123 consecutive patients with chronic venous disease seen at a cardiovascular surgery outpatient clinic. We grouped patients by the worse leg as mild (C1-C2), moderate (C3), or advanced (C4-C6). We compared the index and five other blood count indices between groups, correlated them with the venous clinical severity score, and tested whether they identified advanced disease. Results There were 84 patients with mild, 26 with moderate, and 13 with advanced disease. The median index was 237.1, 331.2, and 187.8, respectively (p=0.53), with no trend across the groups. No other index differed between the groups. The index was not correlated with the venous clinical severity score (rho=0.007, 95% confidence interval -0.17 to 0.18) and showed no statistically significant discrimination for advanced disease (area under the curve 0.454, 95% confidence interval 0.271-0.637). In ordinal regression, it was not associated with disease group (odds ratio per standard deviation, 1.12; 95% confidence interval, 0.76-1.64). Only diabetes was associated with more severe disease. Conclusion In this retrospective cohort, the aggregate index of systemic inflammation and other blood count indices were not significantly associated with the clinical severity of chronic venous disease. Larger studies with more patients with advanced disease are needed.
No takes yet. Share an insight, caveat, or question.
Özer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: